港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

派格生物医药-B

10.200

-0.640-5.90%

成交量：79.96万

成交额：826.24万

市值：39.37亿

市盈率：-12.14

高：10.840

开：10.840

低：10.000

收：10.840

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

GLP-1新锐IPO，核心管线即将上市

异动解读 | 派格生物医药-B盘中暴跌5.02%，延续IPO破发颓势

异动解读 | 港股新股派格生物医药-B盘中大跌5.02%，上市第二日继续下挫

异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%，投资者看好其商业化前景

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02565"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物医药-B","latestPrice":10.2,"timestamp":1748592503030,"preClose":10.84,"halted":0,"volume":799600,"delay":0,"floatShares":279164339,"shares":385955532,"eps":-0.8404179448460801,"marketStatus":"休市中","change":-0.64,"latestTime":"05-30 16:08:23","open":10.84,"high":10.84,"low":10,"amount":8262390,"amplitude":0.077491,"askPrice":10.24,"askSize":12000,"bidPrice":10.2,"bidSize":21500,"shortable":0,"etf":0,"ttmEps":-0.8404179448460801,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1748827800000},"marketStatusCode":7,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":10.84,"openAndCloseTimeList":[[1748568600000,1748577600000],[1748581200000,1748592000000]],"volumeRatio":0.15349667577010448,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":279164339,"roa":"-61.30%","roe":"-224.15%","lyrEps":-0.840418,"volumeRatio":0.15349667577010448,"shares":385955532,"dividePrice":0,"high":10.84,"amplitude":0.077491,"preClose":10.84,"low":10,"week52Low":10,"pbRate":"69.31","week52High":13.5,"institutionHeld":0,"latestPrice":10.2,"committee":0.283582,"eps":-0.8404179448460801,"divideRate":0,"volume":799600,"delay":0,"ttmEps":-0.8404179448460801,"open":10.84,"prevYearClose":15.6,"prevWeekClose":15.6,"prevMonthClose":15.6,"prevQuarterClose":15.6,"fiveDayClose":15.6,"twentyDayClose":15.6,"sixtyDayClose":15.6},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02565\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538012420","title":"GLP-1新锐IPO，核心管线即将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2538012420","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538012420?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 17:32","pubTimestamp":1748424761,"startTime":"0","endTime":"0","summary":"正文共2700字 3图预计阅读时间8分钟2025年5月27日，GLP-1新锐派格生物正式登陆港交所，中金公司担任独家保荐人。产品管线主要围绕GLP-1，致力于为患者提供安全、有效、便捷且具有多重临床获益的创新疗法。当前，全球减重药物市场正经历结构性变革，以GLP-1受体激动剂为代表的创新疗法成为推动行业发展的核心力量。作为GLP-1领域的新兴力量，派格生物正蓄势待发，准备在这红海市场中占据一席之地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528191102a48fc049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528191102a48fc049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"1191654599","title":"异动解读 | 派格生物医药-B盘中暴跌5.02%，延续IPO破发颓势","url":"https://stock-news.laohu8.com/highlight/detail?id=1191654599","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191654599?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 09:56","pubTimestamp":1748397403,"startTime":"0","endTime":"0","summary":"派格生物医药-B今日盘中大跌5.02%，延续了其港股上市首日的颓势。该公司昨日在港交所正式挂牌上市，但首日股价就出现大幅下跌。派格生物医药成立于2008年，专注于自主研究及开发慢性病创新疗法，重点关注内分泌代谢领域。目前，公司有6款候选产品，但尚未有商业化产品。其中，进展最快的是一款GLP-1激动剂PB-119，其针对糖尿病的单药和联合疗法已提交上市注册申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02565"],"gpt_icon":0},{"id":"1188425710","title":"异动解读 | 港股新股派格生物医药-B盘中大跌5.02%，上市第二日继续下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1188425710","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188425710?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 09:56","pubTimestamp":1748397401,"startTime":"0","endTime":"0","summary":"5月28日上午，港股新上市公司派格生物医药-B盘中大跌5.02%，延续了上市首日的跌势，引发投资者关注。派格生物医药于5月27日在港交所正式挂牌上市，发行价为15.6港元。然而，上市首日即遭遇破发，收盘价为11.66港元，大跌25.9%。派格生物医药成立于2008年，专注于自主研究及开发慢性病创新疗法，重点关注内分泌代谢领域。分析人士认为，派格生物医药股价持续下跌，可能与公司尚未盈利且产品未实现商业化有关。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02565"],"gpt_icon":0},{"id":"1113728130","title":"异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%，投资者看好其商业化前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1113728130","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113728130?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 09:35","pubTimestamp":1748396118,"startTime":"0","endTime":"0","summary":"港股上市第二日，派格生物医药-B今日盘中大涨5.36%，引发市场广泛关注。这家专注于自主研发慢性病创新疗法的生物技术公司，正吸引着投资者的目光。派格生物医药于5月27日在港交所成功上市，发行价为15.6港元/股。其核心产品PB-119是一款每周一次的长效GLP-1激动剂，已完成III期试验并在2023年提交国内上市申请，预计将于2025年获得NDA批准并在中国商业化推出。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%，投资者看好其商业化前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02565"],"gpt_icon":1}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2025-05-30","current":-12.743079,"percent":1,"low":-19.497942,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"high":-12.743079,"avg":-14.696197,"sd":2.46554,"marketCap":3936746426},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426}],"updateTime":1748660419452}}}